We’ve recently updated our valuation analysis.

Veris Residential Valuation

Is VRE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for VRE?

Other financial metrics that can be useful for relative valuation.

VRE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue12.1x
Enterprise Value/EBITDA26.2x
PEG Ration/a

Price to Sales Ratio vs Peers

How does VRE's PS Ratio compare to its peers?

The above table shows the PS ratio for VRE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average2.5x
HPP Hudson Pacific Properties
1.4x4.1%US$1.4b
DEA Easterly Government Properties
4.7x4.9%US$1.6b
PGRE Paramount Group
1.7x3.0%US$1.3b
PDM Piedmont Office Realty Trust
2x3.6%US$1.1b
VRE Veris Residential
4x0.09%US$1.6b

Price-To-Sales vs Peers: VRE is expensive based on its Price-To-Sales Ratio (4x) compared to the peer average (2.5x).


Price to Earnings Ratio vs Industry

How does VRE's PE Ratio compare vs other companies in the US REITs Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a4.1%
n/an/an/a

Price-To-Sales vs Industry: VRE is good value based on its Price-To-Sales Ratio (4x) compared to the US REITs industry average (4.9x)


Price to Sales Ratio vs Fair Ratio

What is VRE's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VRE PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4x
Fair PS Ratio2.5x

Price-To-Sales vs Fair Ratio: VRE is expensive based on its Price-To-Sales Ratio (4x) compared to the estimated Fair Price-To-Sales Ratio (2.5x).


Share Price vs Fair Value

What is the Fair Price of VRE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: VRE ($15.94) is trading below our estimate of fair value ($18.94)

Significantly Below Fair Value: VRE is trading below fair value, but not by a significant amount.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst VRE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$15.94
US$17.67
+10.8%
23.0%US$26.00US$13.00n/a6
Nov ’23US$15.73
US$16.29
+3.5%
24.9%US$26.00US$13.00n/a7
Oct ’23US$11.37
US$16.86
+48.3%
23.2%US$26.00US$14.00n/a7
Sep ’23US$13.43
US$16.93
+26.1%
23.5%US$26.00US$13.50n/a7
Aug ’23US$13.83
US$16.50
+19.3%
24.7%US$26.00US$13.00n/a7
Jul ’23US$13.52
US$17.14
+26.8%
22.8%US$26.00US$13.00n/a7
Jun ’23US$16.05
US$18.43
+14.8%
17.4%US$26.00US$16.00n/a7
May ’23US$16.01
US$19.00
+18.7%
15.7%US$26.00US$16.00n/a7
Apr ’23US$17.79
US$19.00
+6.8%
15.7%US$26.00US$16.00n/a7
Mar ’23US$16.79
US$19.29
+14.9%
15.4%US$26.00US$16.00n/a7
Feb ’23US$16.44
US$19.43
+18.2%
14.5%US$26.00US$17.00n/a7
Jan ’23US$18.38
US$19.14
+4.2%
15.4%US$26.00US$16.00n/a7
Dec ’22US$16.49
US$18.50
+12.2%
17.5%US$26.00US$16.00US$15.997
Nov ’22US$18.15
US$18.36
+1.1%
17.9%US$26.00US$16.00US$15.737
Oct ’22US$17.51
US$18.07
+3.2%
18.3%US$26.00US$16.00US$11.377
Sep ’22US$17.97
US$18.21
+1.4%
18.7%US$26.00US$15.00US$13.437
Aug ’22US$18.00
US$17.50
-2.8%
20.2%US$26.00US$15.00US$13.837
Jul ’22US$17.60
US$17.79
+1.1%
28.6%US$30.00US$14.00US$13.527
Jun ’22US$17.74
US$17.21
-3.0%
31.1%US$30.00US$13.00US$16.057
May ’22US$16.36
US$16.43
+0.4%
34.6%US$30.00US$13.00US$16.017
Apr ’22US$15.73
US$16.14
+2.6%
35.6%US$30.00US$13.00US$17.797
Mar ’22US$14.13
US$16.14
+14.2%
35.3%US$30.00US$13.00US$16.797
Feb ’22US$12.63
US$16.14
+27.8%
35.3%US$30.00US$13.00US$16.447
Jan ’22US$12.46
US$16.21
+30.1%
35.0%US$30.00US$13.00US$18.387
Dec ’21US$13.61
US$16.29
+19.7%
35.0%US$30.00US$13.00US$16.497

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies